aon glp-1 study: meds and support programs improve health outcomes | Carla D'Angelo posted on the topic Aon Updates GLP-1 Therapy Analysis
Description
The patent on semaglutide, found in Novo Nordisk's Ozempic and Wegovy weight-loss drugs, expired in India on March 20
This medical cooler case can be taken on board without hassles
With semaglutide no longer in shortage, Novo says compounded versions are not justified
It can lead to weight loss, better glycemic control, and reduced cardiometabolic risk factors
Learn when to increase your semaglutide or tirzepatide dose
Your medication ships discreetly from a licensed compounding pharmacy on a monthly cadence
